Phyllodes tumor is a relatively uncommon fibroepithelial neoplasm of the breast characterized by proliferation of both stromal and epithelial elements. Benign phyllodes tumors are distinguished from fibroadenomas by their prominent leaf-like architecture and exaggerated intracanalicular stromal growth pattern. Typically, these lesions affect older natal females; however, we present what we believe is the first reported case of benign phyllodes tumor in a hormonally treated transgender woman.
YangXKandilDCosarEFKhanA. Fibroepithelial tumors of the breast. Arch Pathol Lab Med. 2014;138:25-36.
2.
TanBYAcsGAppleSKet al. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016;68:5-21.
3.
SapinoABoscoMCassoniPet al. Estrogen receptor-β is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathol. 2006;19:599-606.
4.
AbeMMiyataSNishimuraS. Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors. Breast Cancer. 2011;18:268-272.
5.
BernsteinLDeapenDRossRK. The descriptive epidemiology of malignant cytosarcoma phyllodes tumors of the breast. Cancer. 1993;71:3020-3024.
6.
KrishnamurthySAshfaqRShinHJSneigeN. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem. Cancer. 2000;90:342-349.
7.
LakhaniSREllisIOSchnittSJTanPHvan de VijverMJ, eds. World Health Organzation Classification of Tumours of the Breast. Lyon, France: IARC Press; 2012.
8.
BrogiE. Fibroepithelial neoplasms. In: HodaSABrogiEKoernerFCRosenPP, eds. Rosen’s Breast Pathology. 4th ed.Philadelphia, PA: Lippincott Williams & Wilkins; 2014:213-270.
9.
BowmanEOpreaGOkoliJet al. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients. Breast J. 2012;18:242-247.
10.
BernardesJRSeixasMTLimaGRMarinhoLCGebrimLH. The effect of tamoxifen on PCNA expression in fibroadenomas. Breast J. 2003;9:302-306.
11.
KanhaiRCHageJJBloemenaEvan DiestPJKarimRB. Mammary fibroadenoma in a male-to-female transsexual. Histopathology. 1999;35:183-185.
12.
LemmoGGarceaNCorselloS. Breast fibroadenoma in a male-to-female transsexual patient after hormonal treatment. Eur J Surg Suppl. 2003;588:69-71.
13.
LeeJWNadelmanCMHirschowitzSLDebruhlNDBassettLW. Malignant phyllodes tumor of a genotypic male, phenotypic female with liposarcomatous differentiation. Breast J. 2007;13:308-317.
14.
MaycockLBKennedyHP. Breast care in the transgender individual. J Midwifery Womens Health. 2014;59:74-81.
15.
MurrayMPBrogiE. Benign proliferative lesions of the male breast. In: HodaSABrogiEKoernerFCRosenPP, eds. Rosen’s Breast Pathology. 4th ed.Philadelphia, PA: Lippincott Williams & Wilkins; 2014:957-969.
16.
WierckxKGoorenLT’SjoenT. Clinical review: breast development in trans women receiving cross-sex hormones. J Sex Med. 2014;11:1240-1247.
17.
KanhaiRCHageJJvan DiestPJBloemenaEMulderJW. Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men. Am J Surg Pathol. 2000;24:74-80.
18.
PhillipsJFein-ZacharyVJMehtaTSLittlehaleNVenkataramanSSlanetzPJ. Breast imaging in the transgender patient. AJR Am J Roentgenol. 2014;202:1149-1156.
